Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-04-18
2006-04-18
Woitach, Joseph (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S455000, C435S825000, C435S320100, C424S450000
Reexamination Certificate
active
07030097
ABSTRACT:
One aspect of the present invention relates to a nucleic acid delivery system including a polymeric structure formed of a biocompatible polymer and a mixture comprising one or more nucleic acid molecules and a first co-dispersant, the mixture being contained within the polymeric structure, wherein the first co-dispersant is present in an amount effective to control diffusion of the one or more nucleic acid from the polymeric structure. Compositions including the nucleic acid delivery system and a pharmaceutically-acceptable carrier are disclosed. Methods of making the nucleic acid delivery system and their use in delivering nucleic acid into a patient and modifying gene expression in a target cell are also disclosed.
REFERENCES:
patent: 4900556 (1990-02-01), Wheatley
patent: 5286493 (1994-02-01), Oshlack
patent: 5445609 (1995-08-01), Lattin et al.
patent: 5543156 (1996-08-01), Roorda
patent: 5593697 (1997-01-01), Barr et al.
patent: 5603960 (1997-02-01), O'Hagan et al.
patent: 5635216 (1997-06-01), Thompson
patent: 5741521 (1998-04-01), Knight et al.
patent: 5763157 (1998-06-01), Treml
patent: 5763416 (1998-06-01), Bonadio et al.
patent: 5783567 (1998-07-01), Hedley et al.
patent: 5792477 (1998-08-01), Rickey et al.
patent: 5811128 (1998-09-01), Tice et al.
patent: 5814344 (1998-09-01), Tice et al.
patent: 5831020 (1998-11-01), Cirovsky
patent: 5853763 (1998-12-01), Tice et al.
patent: 5869103 (1999-02-01), Yeh et al.
patent: 5879713 (1999-03-01), Roth et al.
patent: 6040295 (2000-03-01), Rolland et al.
patent: 6191257 (2001-02-01), Ledley et al.
patent: 6262034 (2001-07-01), Mathiowitz et al.
patent: 6268053 (2001-07-01), Woiszwillo
patent: 6309669 (2001-10-01), Setterstrom
patent: 6312727 (2001-11-01), Schacht et al.
patent: 6312731 (2001-11-01), Staas et al.
patent: 6344436 (2002-02-01), Smith et al.
patent: 6375944 (2002-04-01), Trinchieri et al.
patent: 6429199 (2002-08-01), Krieg
patent: 6509146 (2003-01-01), Bronshtein
patent: 6667294 (2003-12-01), Jones et al.
patent: 6743444 (2004-06-01), Jones et al.
patent: 2002/0065213 (2002-05-01), Debs
patent: 0 827 741 (1998-03-01), None
Abe et al., Enhanced Gene Transfer with Fusogenic Liposomes Containing Vesicular Stomatitis Virus G Glycoprotein, Jul. 1998, Journal of Virology, pp. 6159-6163.
Yong et al., Controlled release of plasmid DNA, 1997, Journal of Controlled Release, vol. 47, pp. 123-134.
Jones et al., “Poly(DL-lactide-co-glycolide)-encapsulated Plasmid DNA Elicits Systemic and Mucosal Antibody Responses to Encoded Protein After Oral Administration,”Vaccine15(8):814-817 (1997).
Saltzman et al., “Transport Rates of Protein in Porous Materials with Known Microgeometry,”Biophys. J. 55:163-171 (1989).
Langer et al., “Polymers for the Sustained Release of Proteins and Other Macromolecules,”Nature263:797-800 (1976).
Mathiowitz et al., “Biologically Erodable Microspheres as Potential Oral Drug Delivery Systems,”Nature386:410-414 (1997).
Labhasetwar et al., “A DNA Controlled-release Coating for Gene Transfer: Transfection in Skeletal and Cardiac Muscle,”Journal of Pharmaceutical Sciences87(11):1347-1350 (1998).
Krewson et al., “Stabilization of Nerve Growth Factor in Controlled Release Polymers and in Tissue,”J. Biomater. Sci. Polymer Edn. 8(2):103-117 (1996).
Belcheva Nadya D.
Luo Dan
Saltzman William Mark
Shen Hong
Woodrow-Mumford Kim
Cornell Research Foundation Inc.
Kelly Robert M.
Nixon & Peabody LLP
Woitach Joseph
LandOfFree
Controlled nucleic acid delivery systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled nucleic acid delivery systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled nucleic acid delivery systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3586109